Cancer Family
Central Nervous System Neoplasm
CI-CAN-00000118Explore in graph →
Non-malignant1,345 active trials7 approved drugs177 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000118Explore in graph →
Clinical trials
5,060 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01089868 | Usefulness of Therapy Monitoring by Means of [(18)F]Fluoroethyltyrosine-Positron Emission Tomography (FET-PET) in Glioblastoma Multiforme Patients | completed | — | 79 | Ludwig-Maximilians - University of MunichOTHER | 1 | Aug 7, 2012 | clinicaltrials |
| NCT00352820 | Experience of Brain Tumor Caregivers | completed | — | 40 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 1, 2012 |
| clinicaltrials |
| NCT00430872 | Development of the MDASI-Spine Tumor Module | completed | — | 128 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 1, 2012 | clinicaltrials |
| NCT00822432 | Coproporphyrine Isomers and Methotrexate Elimination(COMETH) | completed | — | 85 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Jul 31, 2012 | clinicaltrials |
| NCT01240460 | Exploratory Study of XL765 (SAR245409) or XL147 (SAR245408) in Subjects With Recurrent Glioblastoma Who Are Candidates for Surgical Resection | completed | Phase 1 | 40 | SanofiINDUSTRY | 1 | Jul 27, 2012 | clinicaltrials |
| NCT01650922 | Molecular Genetic Studies of Childhood Brain Tumors and Blood Samples | completed | — | 4 | Stanford UniversityOTHER | 1 | Jul 26, 2012 | clinicaltrials |
| NCT01130220 | Study of the Health Information Needs of Brain Cancer Patients | completed | — | 27 | University of FloridaOTHER | 1 | Jul 25, 2012 | clinicaltrials |
| NCT00389883 | Anaesthesia for Supratentorial Tumor Resection | completed | Phase 3 | 69 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Jul 10, 2012 | clinicaltrials |
| NCT01635140 | Hypofractionated Radiotherapy Versus Conventional Radiotherapy in Diffuse Brainstem Glioma in Children | completed | Phase 3 | 64 | Children's Cancer Hospital Egypt 57357OTHER | 1 | Jul 9, 2012 | clinicaltrials |
| NCT00624728 | Assessment of 18FLT PET-CT for Volume Definition of High-grade Gliomas (GLIO-TEP)(GLIO-TEP) | completed | Phase 1 / Phase 2 | 21 | University Hospital, BordeauxOTHER | 1 | May 4, 2012 | clinicaltrials |
| NCT00379470 | Effect of NovoTTF-100A in Recurrent Glioblastoma Multiforme (GBM) | completed | Phase 3 | 236 | NovoCure Ltd.INDUSTRY | 7 | May 1, 2012 | clinicaltrials |
| NCT00970788 | A Pilot Study of Using Video Images in Advance Care Planning in Malignant Glioma Patients | completed | N/A | 50 | Massachusetts General HospitalOTHER | 1 | May 1, 2012 | clinicaltrials |
| NCT01167322 | Study of NPC-07 for Fluorescence-guided Resection of Malignant Gliomas | completed | Phase 3 | 45 | NobelpharmaINDUSTRY | 1 | Apr 27, 2012 | clinicaltrials |
| NCT00241670 | Fluorescence-guided Resection of Malignant Gliomas With 5-Aminolevulinic Acid | completed | Phase 3 | 415 | medac GmbHINDUSTRY | 0 | Apr 26, 2012 | clinicaltrials |
| NCT00404495 | Combination of Irinotecan and Temozolomide in Children With Brain Tumors. | completed | Phase 2 | 83 | PfizerINDUSTRY | 8 | Apr 18, 2012 | clinicaltrials |
| NCT00132158 | ZD1839 and Oral Irinotecan in Treating Young Patients With Refractory Solid Tumors | completed | Phase 1 | 19 | St. Jude Children's Research HospitalOTHER | 1 | Apr 17, 2012 | clinicaltrials |
| NCT00147160 | Phase II Cisplatin + Temozolomide in Malignant Glial Tumours in Children and Adolescents | completed | Phase 2 | 87 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 2 | Apr 11, 2012 | clinicaltrials |
| NCT01285414 | Verubulin, Radiation Therapy, and Temozolomide to Treat Patients With Newly Diagnosed Glioblastoma Multiforme | completed | Phase 2 | 5 | Myrexis Inc.INDUSTRY | 1 | Apr 11, 2012 | clinicaltrials |
| NCT00777686 | Measuring Non-Enhancing Glioblastoma Progression | completed | — | 7 | M.D. Anderson Cancer CenterOTHER | 1 | Mar 30, 2012 | clinicaltrials |
| NCT00945828 | Assessing the Effectiveness of Individual Education Plans for Childhood Cancer Survivors | completed | N/A | 62 | University of MiamiOTHER | 1 | Mar 8, 2012 | clinicaltrials |
| NCT00581737 | Cognitive Functioning and Quality of Life in CNS Lymphoma | completed | — | 50 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Mar 5, 2012 | clinicaltrials |
| NCT00972790 | Scalp Nerve Blocks for Post-Craniotomy Pain | completed | N/A | 89 | Unity Health TorontoOTHER | 1 | Mar 1, 2012 | clinicaltrials |
| NCT00412542 | Thalidomide and Temozolomide or Camptothecin-11 (CPT-11) in Patients With Gliomas | completed | Phase 2 | 78 | M.D. Anderson Cancer CenterOTHER | 1 | Feb 28, 2012 | clinicaltrials |
| NCT00214175 | Determination of Fraction Size Equivalent Dose (FED) Levels for Intracranial Conformal Avoidance Radiotherapy | completed | — | 44 | University of Wisconsin, MadisonOTHER | 1 | Feb 24, 2012 | clinicaltrials |
| NCT00460395 | Surgery Versus Stereotactic Radiosurgery in the Treatment of Single Brain Metastasis: A Randomized Trial | completed | Phase 3 | 64 | M.D. Anderson Cancer CenterOTHER | 1 | Feb 24, 2012 | clinicaltrials |
| NCT00036569 | A Phase II Study of Pegylated Interferon Alfa 2b (PEG-Intron(Trademark)) in Children With Diffuse Pontine Gliomas | completed | Phase 2 | 32 | National Cancer Institute (NCI)NIH | 1 | Feb 13, 2012 | clinicaltrials |
| NCT00973557 | The Effect of Monoclonal Vascular Endothelial Growth Factor (VEGF) Antibody (Bevacizumab) on Pituitary Function | completed | — | 6 | Cedars-Sinai Medical CenterOTHER | 1 | Feb 7, 2012 | clinicaltrials |
| NCT00631670 | Stereotactic Body Radiation Therapy (SBRT) for Tumors Near the Spinal Cord | completed | N/A | 21 | University of FloridaOTHER | 1 | Feb 3, 2012 | clinicaltrials |
| NCT00071539 | Safety and Efficacy Study to Treat Recurrent Grade 4 Malignant Brain Tumors | completed | Phase 2 | 56 | Teva Branded Pharmaceutical Products R&D, Inc.INDUSTRY | 0 | Jan 20, 2012 | clinicaltrials |
| NCT00504660 | 6-TG, Capecitabine and Celecoxib Plus TMZ or CCNU for Anaplastic Glioma Patients | completed | Phase 2 | 75 | M.D. Anderson Cancer CenterOTHER | 1 | Jan 11, 2012 | clinicaltrials |
| NCT01502241 | Phase III Trial of Primary Radio- or Chemotherapy in Malignant Astrocytoma of the Elderly(Methusalem) | completed | Phase 3 | 412 | Heidelberg UniversityOTHER | 2 | Dec 30, 2011 | clinicaltrials |
| NCT00817284 | Bevacizumab and Irinotecan or Bevacizumab and Temozolomide With Concomitant Radiotherapy for Primary Glioblastoma Multiforme (GBM) | completed | Phase 2 | 60 | Ulrik LassenOTHER | 1 | Nov 30, 2011 | clinicaltrials |
| NCT00047879 | Phase II Trial of Peginterferon Alpha-2b and Thalidomide in Adults With Recurrent Gliomas | completed | Phase 2 | 7 | National Cancer Institute (NCI)NIH | 1 | Oct 26, 2011 | clinicaltrials |
| NCT00184353 | Clinical MR Spectroscopy of Brain Metastases at 1,5T and 3T. | completed | — | 19 | Norwegian University of Science and TechnologyOTHER | 1 | Oct 21, 2011 | clinicaltrials |
| NCT00892931 | Phase 2 Study MPC-6827 for Recurrent Glioblastoma Multiforme | completed | Phase 2 | 56 | Myrexis Inc.INDUSTRY | 1 | Oct 14, 2011 | clinicaltrials |
| NCT00002794 | Carboplatin Plus Vincristine in Treating Children With Retinoblastoma | completed | Phase 2 | 25 | St. Jude Children's Research HospitalOTHER | 1 | Oct 4, 2011 | clinicaltrials |
| NCT00004006 | Combination Chemotherapy, Radiation Therapy, and Bone Marrow Transplantation in Treating Patients With Retinoblastoma | completed | Phase 2 | 4 | St. Jude Children's Research HospitalOTHER | 1 | Oct 4, 2011 | clinicaltrials |
| NCT01225003 | Advanced MR Techniques in Detection of Tumor Infiltration and Grading in Gliomas | completed | — | 30 | Universitaire Ziekenhuizen KU LeuvenOTHER | 1 | Sep 29, 2011 | clinicaltrials |
| NCT00715013 | Patupilone (EPO 906) in Patients With Recurrent or Progressive Glioblastoma | completed | Phase 1 / Phase 2 | 9 | University of ZurichOTHER | 0 | Sep 15, 2011 | clinicaltrials |
| NCT00509301 | Safety & Radiation Distribution Study of Cotara® in Patients With Recurrent Glioblastoma Multiforme | completed | Phase 1 | 12 | Peregrine PharmaceuticalsINDUSTRY | 1 | Aug 5, 2011 | clinicaltrials |
| NCT00010114 | Genetic Study of Newly Diagnosed Central Nervous System Tumors in Young Children | completed | — | 83 | Pediatric Brain Tumor ConsortiumNETWORK | 1 | Jul 20, 2011 | clinicaltrials |
| NCT00600054 | Phase 2 Study of Nimotuzumab in Pediatric Recurrent Diffuse Intrinsic Pontine Glioma | completed | Phase 2 | 44 | YM BioSciencesINDUSTRY | 3 | Jul 6, 2011 | clinicaltrials |
| NCT00089427 | IL13-PE38QQR Infusion After Tumor Resection, Followed by Radiation Therapy With or Without Temozolomide in Patients With Newly Diagnosed Malignant Glioma | completed | Phase 1 | 24 | INSYS Therapeutics IncINDUSTRY | 1 | Jul 4, 2011 | clinicaltrials |
| NCT00440570 | A Study of Therapeutic Amplitude-modulated Electromagnetic Fields in Advanced Tumors(THBC001) | completed | Early Phase 1 | 2 | Pasche, Boris, M.D.INDIV | 1 | Jun 29, 2011 | clinicaltrials |
| NCT00463203 | Bevacizumab and Irinotecan for Patients With Primary Brain Tumors and Progression After Standard Therapy | completed | Phase 2 | 54 | Rigshospitalet, DenmarkOTHER | 1 | Jun 29, 2011 | clinicaltrials |
| NCT00024557 | Histologic Effect/Safety of Pre/Post-Operative IL13-PE38QQR in Recurrent Resectable Supratentorial Malignant Glioma Patients | completed | Phase 1 | 40 | INSYS Therapeutics IncINDUSTRY | 1 | Jun 6, 2011 | clinicaltrials |
| NCT00041587 | Pre-operative IL13-PE38QQR in Patients With Recurrent or Progressive Malignant Glioma | completed | Phase 1 / Phase 2 | 80 | INSYS Therapeutics IncINDUSTRY | 3 | Jun 6, 2011 | clinicaltrials |
| NCT00064779 | Imaging Study of the Distribution of IL13-PE38QQR Infused Before and After Surgery in Adult Patients With Recurrent Malignant Glioma | completed | Phase 1 | 18 | INSYS Therapeutics IncINDUSTRY | 1 | Jun 6, 2011 | clinicaltrials |
| NCT00076986 | The PRECISE Trial: Study of IL13-PE38QQR Compared to GLIADEL Wafer in Patients With Recurrent Glioblastoma Multiforme | completed | Phase 3 | 300 | INSYS Therapeutics IncINDUSTRY | 6 | Jun 6, 2011 | clinicaltrials |
Data updated 23 days agoSource updated Aug 7, 2012source: clinicaltrials